🚨 NOW: POTUS is back at the White House meeting with NATO Secretary General Mark Rutte in the Oval Office
This was supposed to be a CLOSED DOOR meeting. But Trump just invited the press in 👀
This is the same NATO Secretary who called Trump "DADDY" last year 🤣
On one hand, Mamdani is charismatic and that’s a short cut to putting people in power. On the other hand, these people are weirdos with weirdo beliefs. @GetHammeredPod
President Trump’s message to Senate Republicans was clear:
(1) We need our voters to show up in November—so we can win.
(2) They need us to pass the SAVE America Act.
(3) There are multiple ways to pass the SAVE America Act in the Senate.
He’s right.
Let’s go!
It happened on J6
Video proof of Roseanne Boyland being murdered by Officer Lila Morris with pre meditated motive.
Stay to the end as Roseanne's lifeless body is dragged away.
I have included a court document where Lila Morris says
"I'm gonna go over there and fvck all of them[Trump Supporters]up. If they bring their dumb white asses iver to th Capitol, I'm fvcking them up."
Unfortunately, Roseanne Boyland was the Trump supporter that was closest to Lila Morris and a corrupt democrat, violent, evil, racist liberal cop got her wish and murdered a white Trump supporter.
The DC and Metro police investigated themselves and found themselves innocent. The coroner faked an autopsy stating Roseanne ODd on Adderall an Rx she had been on for a decade, virtually impossible to do.
Police Beating of Unconscious Trump Supporter Was ‘Objectively Reasonable,’ Department Rules.
Black democrat cops who hate trump killed white Trump supporters that day. Trump Derangement Syndrome caused by propaganda media transfers to American citizens and J6ers are the figurehead of that. See comments for proof.
God Bless the J6ers
So @nytimes did an entire investigation on Diana Russini where they teed off on NYT leadership, including the CEO, and The Athletic leadership too. https://t.co/av66yzuyQW
.@SenTuberville: What's in the SAVE America Act needs to stay. President Trump's right here. If we don't do something with the filibuster, and we don't get things passed, it'll be the last time we have a Republican President or a Republican Congress. The ball's in our court.
We had a great lunch with President Trump. I'm thankful for his leadership on the world stage & at home.
And he’s right—the American people want to see Republicans fight for our country. We can’t allow Democrats’ obstruction to stop the America First agenda Americans voted for.
I had the opportunity to check out the undercroft beneath the Lincoln Memorial, which officially opens to the public tomorrow.
Before the memorial was built, much of this area along the National Mall was swampy ground. The undercroft showcases the massive support structure that made this iconic landmark possible and offers a fascinating look at its history.
The Department of the Interior has worked hard to make this space accessible to the public. There is a lot of exciting work underway in Washington as we prepare to celebrate America's 250th anniversary, and this is a great addition for visitors to our nation's capital
Now that we know the political significance of my $8.75 coral maternity dress from Old Navy, can’t wait to hear what the New York Times has to say about my elastic-waistband pants and compression socks! In the meantime, enjoy my pregnancy fashion (or lack thereof) and a good story with your kids on Storytime with the Second Lady.
https://t.co/UmdeTtU60L
🇺🇸 TONIGHT 🇺🇸
I’m honored to help kick off the Great American State Fair on the National Mall, headlined by President Trump!
America’s 250th Birthday - LET’S GO!
RSVP NOW or TUNE IN LIVE! @Freedom250
📍 National Mall, Washington DC
🕖 7:00 PM ET
🚪 Doors Open: 3:30 PM
Personal News: I am writing as a mother and living organ donor.
Twenty years ago this month, our youngest son Peter received a life-saving liver transplant at UPMC Children’s Hospital of Pittsburgh @ChildrensPgh
With Peter’s permission, I’m sharing a photo taken with his older brother a few weeks before his 2006 transplant, when he was in liver failure.
Four years later, he won gold at the U.S. Transplant Games in Madison, Wisconsin. And here he is today—healthy, strong, and thriving.
What I didn’t fully appreciate in 2006 was that Peter and I were part of pioneering research aimed at reducing the risk of organ rejection in pediatric patients.
Even though I donated a segment of my liver to Peter—and as mother and son we are genetically similar—the new testing protocol still helped lower his chances of rejection.
Peter and I participated in a research project that developed a simple blood test called Pleximmune @plexision
It predicts the likelihood of rejection in pediatric patients by analyzing the unique immune chemistry of both the child and the donor.
The test also helps doctors determine exactly how much immunosuppression a child needs to keep rejection at bay.
Our family knows firsthand how valuable this early warning system truly is.
When Peter hit his growth spurt in his early teens, like so many pediatric transplant recipients, he needed increased immunosuppression.
The Pleximmune test predicted this need months in advance, giving his doctors time to adjust his care before problems arose.
The threat of rejection is a cloud that hangs over every transplant patient and family.
This test is making a real difference. It helps prevent rejection and can save tens of thousands of dollars for families and insurance companies.
This is where common sense matters.
In early July, the research team is preparing an appeal to Medicare @MedicareGov to price the Pleximmune test "fairly and consistently" with similar diagnostic tests.
Right now, only a small percentage of the cost of the test for pediatric patients is being reimbursed.
As the team told me, “Fair pricing is the lifeblood of a company’s ability to provide patients with more informed care and continued innovation.”
Today, Pleximmune has been used to test roughly 10% of children under age 21 who have received liver or intestine transplants in the U.S.
If you want to support this important work and help more pediatric patients and their families benefit...
Send a note to your senator, let them know to escalate the matter with Medicare so the appeal gets a fair hearing.
Catherine
Personal News: I am writing as a mother and living organ donor.
Twenty years ago this month, our youngest son Peter received a life-saving liver transplant at UPMC Children’s Hospital of Pittsburgh @ChildrensPgh
With Peter’s permission, I’m sharing a photo taken with his older brother a few weeks before his 2006 transplant, when he was in liver failure.
Four years later, he won gold at the U.S. Transplant Games in Madison, Wisconsin. And here he is today—healthy, strong, and thriving.
What I didn’t fully appreciate in 2006 was that Peter and I were part of pioneering research aimed at reducing the risk of organ rejection in pediatric patients.
Even though I donated a segment of my liver to Peter—and as mother and son we are genetically similar—the new testing protocol still helped lower his chances of rejection.
Peter and I participated in a research project that developed a simple blood test called Pleximmune @plexision
It predicts the likelihood of rejection in pediatric patients by analyzing the unique immune chemistry of both the child and the donor.
The test also helps doctors determine exactly how much immunosuppression a child needs to keep rejection at bay.
Our family knows firsthand how valuable this early warning system truly is.
When Peter hit his growth spurt in his early teens, like so many pediatric transplant recipients, he needed increased immunosuppression.
The Pleximmune test predicted this need months in advance, giving his doctors time to adjust his care before problems arose.
The threat of rejection is a cloud that hangs over every transplant patient and family.
This test is making a real difference. It helps prevent rejection and can save tens of thousands of dollars for families and insurance companies.
This is where common sense matters.
In early July, the research team is preparing an appeal to Medicare @MedicareGov to price the Pleximmune test "fairly and consistently" with similar diagnostic tests.
Right now, only a small percentage of the cost of the test for pediatric patients is being reimbursed.
As the team told me, “Fair pricing is the lifeblood of a company’s ability to provide patients with more informed care and continued innovation.”
Today, Pleximmune has been used to test roughly 10% of children under age 21 who have received liver or intestine transplants in the U.S.
If you want to support this important work and help more pediatric patients and their families benefit...
Send a note to your senator, let them know to escalate the matter with Medicare so the appeal gets a fair hearing.
Catherine